Back to mobile site

Vaxcyte (PCVX) PT Raised to $56 at Jefferies

November 8, 2022 8:15 AM EST Send to a Friend
Jefferies analyst Roger Song raised the price target on Vaxcyte (NASDAQ: PCVX) to $56.00 (from $50.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login